Journal
CELL HOST & MICROBE
Volume 27, Issue 2, Pages 173-175Publisher
CELL PRESS
DOI: 10.1016/j.chom.2020.01.018
Keywords
-
Categories
Ask authors/readers for more resources
Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
